A randomized, double-blind, placebo-controlled trial of interferon-α and amantadine versus interferon-α alone in the treatment of patients with chronic hepatitis C

被引：2
|
作者：
Ahmad, J [1 ]
Vargas, H [1 ]
Balan, V [1 ]
Rakela, J [1 ]
Shakil, AO [1 ]
机构：
[1] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA
来源：
DIGESTIVE DISEASES AND SCIENCES | 2002年 / 47卷 / 07期
关键词：
Public Health; Hepatitis; Chronic Hepatitis; Amantadine;
D O I：
10.1023/A:1015804227191
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1655 / 1656
页数：2
相关论文
共 50 条
  • [1] LETTER: A Randomized, Double-Blind, Placebo-Controlled Trial of Interferon-α and Amantadine Versus Interferon-α Alone in the Treatment of Patients with Chronic Hepatitis C
    Jawad Ahmad
    Hugo Vargas
    Vijayan Balan
    Jorge Rakela
    A. Obaid Shakil
    [J]. Digestive Diseases and Sciences, 2002, 47 : 1655 - 1656
  • [2] Randomized, placebo-controlled, double-blind trial with interferon-α with and without amantadine sulphate in primary interferon-α nonresponders with chronic hepatitis C
    Teuber, G
    Berg, T
    Naumann, U
    Raedle, J
    Brinkmann, S
    Hopf, U
    Zeuzem, S
    [J]. JOURNAL OF VIRAL HEPATITIS, 2001, 8 (04) : 276 - 283
  • [3] Interferon and amantadine in naive chronic hepatitis C: A double-blind, randomized, placebo-controlled trial
    Helbling, B
    Stamenic, I
    Viani, F
    Gonvers, JJ
    Dufour, JF
    Reichen, J
    Cathomas, G
    Steuerwald, M
    Borovicka, J
    Sagmeister, M
    Renner, EL
    [J]. HEPATOLOGY, 2002, 35 (02) : 447 - 454
  • [4] Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-α and ribavirin:: results from a randomized, placebo-controlled, double-blind trial
    Kronenberger, Bernd
    Berg, Thomas
    Herrmann, Eva
    Hinrichsen, Holger
    Gerlach, Tilman
    Buggisch, Peter
    Spenglerf, Ulrich
    Goeserg, Tobias
    Nasser, Samer
    Wursthorn, Karsten
    Pape, Gerd R.
    Hopf, Uwe
    Zeuzem, Stefan
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2007, 19 (08) : 639 - 646
  • [5] A randomized, double blind, placebo controlled trial of interferon-alfa and amantadine versus interferon-alfa alone in the treatment of chronic hepatitis C.
    Shakil, AO
    Balan, V
    Vargas, H
    Gartner, K
    Rakela, J
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A1487 - A1487
  • [6] Interferon-α alone versus interferon-α plus ribavirin in patients with chronic hepatitis C not responding to previous interferon-α treatment
    Tripi, S
    Di Gaetano, G
    Soresi, M
    Cartabellotta, F
    Vassallo, R
    Carroccio, A
    Anastasi, G
    Montalto, G
    [J]. BIODRUGS, 2000, 13 (04) : 299 - 304
  • [7] Randomized, double-blind, placebo-controlled trial of interferon Alfa2a with and without amantadine as initial treatment for chronic hepatitis C
    Zeuzem, S
    Teuber, G
    Naumann, U
    Berg, T
    Raedle, J
    Hartmann, S
    Hopf, U
    [J]. HEPATOLOGY, 2000, 32 (04) : 835 - 841
  • [8] Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naive patients with chronic hepatitis C
    Thuluvath, PJ
    Maheshwari, A
    Mehdi, J
    Fairbanks, KD
    Wu, LLW
    Gelrud, LG
    Ryan, MJ
    Anania, FA
    Lobis, IF
    Black, M
    [J]. GUT, 2004, 53 (01) : 130 - 135
  • [9] Amantadine therapy for chronic hepatitis C - A Randomized double-blind placebo-controlled trial
    Smith, JP
    Riley, TR
    Devenyi, A
    Bingaman, SI
    Kunselman, A
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2004, 19 (06) : 662 - 668
  • [10] Low-dose oral interferon-α in the treatment of chronic viral hepatitis type B:: A double-blind, randomized, placebo-controlled, clinical trial
    Yasuda, K
    Ohashi, Y
    Matsushima, T
    Kumada, H
    Hino, K
    Ito, M
    Takeuchi, T
    Kakumu, S
    Kuroki, T
    Hayashi, N
    Sata, M
    Iino, S
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (05): : 245 - 254
12345